A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Name: A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Published: 2021
License: Public Domain

Lepu Biopharma Co., Ltd. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

egfr

advanced or metastatic biliary tract cancer, mrg003, antibody drug conjugate (adc), egfr, biliary tract cancer, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Related documents